Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily fluticasone furoate nasal spray 110 mcg in perennial allergic rhinitis
2007-006562-15Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in perennial rhinitis comparing Fluticasone furoate nasal spray with Vehicle placebo nasal spray (2 arms). Primary endpoint: Mean change from baseline in daily reflective total nasal symptom score (rTNSS) over the entire treatment period. Started Feb 2008; status: completed.
02
Drugs
fluticasone
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2007-006562-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006562-15.